Navigation Links
Studies Decipher How Anti-Smoking Drugs Work
Date:1/3/2011

MONDAY, Jan.3 (HealthDay News) -- Two drugs that help people stop smoking -- bupropion and varenicline -- may change the way the brain reacts to seeing someone else smoke, new studies report.

And that may be how they cut cravings.

Bupropion (Wellbutrin, Zyban) is prescribed around the world to help people resist smoking cues. But it has not been clear how the drug does this. Using brain scans, Christopher S. Culbertson, of the University of California, Los Angeles, and his colleagues examined what happened in the brains of 30 smokers who took the drug or a placebo for eight weeks.

The researchers gauged how much the participants craved cigarettes by asking them to respond after watching "neutral" cues that did not involve smoking or 45-second videos of actors and actresses smoking.

Those who took the drug instead of the placebo reported less craving. They also showed less activity in areas of the brain linked to craving.

"These results demonstrate that treatment with bupropion is associated with an improved ability to resist cue-induced craving and a reduction in cue-induced activation of limbic and prefrontal brain regions," the study authors wrote.

In a second study, Teresa Franklin of the University of Pennsylvania and her colleagues used brain scans to study how the brains of 22 smokers reacted when they took the drug varenicline (Chantix) or a placebo for three weeks. The participants watched 10-minute videos, some of which included smoking cues.

Those who took the drug had less brain activity in some areas and reported less craving after they saw the videos designed to provide smoking cues.

"The results of our study reveal a distinctive new action of varenicline that may contribute to its clinical efficacy," the researchers wrote. "Unsuccessful smoking cessation is more prevalent in individuals with psychiatric illness, suggesting that they have greater difficulty quitting. Varenicline and other medications that can reduce both withdrawal and cue reactivity may be of special benefit to these subgroups."

Both studies were published online Jan. 3 in the Archives of General Psychiatry.

More information

The American Cancer Society has information on quitting smoking.

-- Randy Dotinga

SOURCE: Archives of General Psychiatry, news release, Jan. 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New trial studies link between stroke and atrial fibrillation
2. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
3. Studies highlight role of stem cell transplant procedures for blood cancer treatment
4. 2 studies provide insight into stroke risk and prevention in young sickle cell anemia patients
5. Drug-like compound stops thyroid overstimulation in early NIH studies
6. Laboratory studies show promise for new multiple sclerosis treatment
7. A Little Alcohol May Help the Heart: Studies
8. Studies validate use of family health history as gold standard in disease risk assessment
9. Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies
10. Practice-changing studies on how oncologists treat cancer to be presented at ASTRO Annual Meeting
11. Studies show everolimus-eluting stent implantation reduces restenosis and repeat revasculariztion
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies Decipher How Anti-Smoking Drugs Work
(Date:1/23/2017)... ... January 23, 2017 , ... ... companies, has achieved ISO 17100:2015 certification following a comprehensive audit performed by ... globally recognized standard that establishes guidance for critical processes within translation, quality ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the highly acclaimed series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, ... technology behind SmartCap, which was founded in 2008 to address the limitations of ...
(Date:1/23/2017)... FL (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have ... strength and improve balance. Kumo Board is the first and only balance board ... it to be soft and rigid at the same time as well as skill-level adjustable ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... about the benefits of making new water infrastructure a number one priority. “As we ... we expect water infrastructure to become a top priority of our new political change ...
(Date:1/23/2017)... ... 23, 2017 , ... Zachary Cattell, President of the Indiana ... industry expert at the 2017 Sector Summit hosted by Ivy Tech Community College ... Gerry Dick, will feature an employer and an association representative from five of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Varias ... enal) y el riesgo de ... a pabetalone    Resverlogix Corp. ("Resverlogix" ... preliminares de un ensayo en fase 1 con sede ... riñón (renal) severa. Los datos demostraron unos resultados importantes ...
(Date:1/23/2017)... January 23, 2017 Longer life expectancy and rising ... global market for medical device technologies. BCC Research reveals in ... Asia-Pacific region, should see strong growth due to rising ... incomes. Continue Reading ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology: